Printer Friendly

Cardiopathia fantastica.

Date of Original Release: January 1, 2004

Term of Approval: 1 Year * Credit Expires: January 1, 2005

Estimated Time for Completion: 2 Hours

The following section was designed for physicians in all specialties, especially those in primary care. The Southern Medical Association is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials. The Southern Medical Association designates this educational activity for a maximum of 1 hour in Category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity. The Featured CME Topic is a CME activity developed and administered by the Southern Medical Association's Department of Education. To obtain Category 1 credit, follow the instructions at the end of the section.

Purpose and Objectives

Cardiopathia fantastica is the cardiac variation of Munchausen syndrome, a rare condition in which a patient repeatedly seeks medical care for factitious illnesses. First reported in 1953, it is characterized by clinical manifestations of acute cardiac disease that are feigned and recurrent. Patients typically present with pain simulating coronary artery disease and are often willing to undergo expensive, invasive, and risky procedures to evaluate their simulated illness. After reading the following article, physicians will be better able to recognize the condition, as well understand the manifestations and treatment of Cardiopathia fantastica


In publishing this section in Southern Medical Journal, the Southern Medical Association recognizes educational needs of physicians in all specialties, especially those in primary care, for current information regarding Cardiopathia fantastica. In this section, authors may have included discussions about drug interventions, whether approved or unapproved by the U.S. Food and Drug Administration. Therefore, it is incumbent on physicians reading this section to be aware of these factors in interpreting the contents and evaluating recommendations. Moreover, views of authors do not necessarily reflect the opinions of the Southern Medical Association. Every effort has been made to encourage the author to disclose any commercial relationships or personal benefit that may be associated with this section. If the author disclosed a relationship, it is indicated below. This disclosure in no way implies that the information presented is biased or of lesser quality, but allows participants to make informed judgments regarding program content.


The primary purpose of this section in the Journal is education. Information presented and techniques discussed are intended to inform physicians of medical knowledge, clinical procedures, and experiences of physicians willing to share such information with colleagues. It is recognized that a diversity of professional opinions exists in the contemporary practice of medicine that influences the selection of methods and procedures. The views and approaches of authors are offered solely for educational purposes. The Southern Medical Association disclaims any and all liability for injury or other damages to any individual reading this section and for all claims that may result from the use of techniques and procedures presented in it.

Ted A. Park, MD; Mark Andrew Borsch, MD; Allen R. Dyer, MD, PHD; and Alan N. Peiris, MD, PHD

Grant/Research Support:


Speaker's Bureau:

Stock Shareholder:

Other Support:
COPYRIGHT 2004 Southern Medical Association
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:CME Topic
Author:Peiris, Alan N.
Publication:Southern Medical Journal
Date:Jan 1, 2004
Previous Article:Intralesional interferon-[alpha]-2B injections for the treatment of Peyronie's disease.
Next Article:Cardiopathia fantastica: the Cardiac variant of Munchausen syndrome.

Related Articles
Letter from the Editor.
Selective estrogen receptor modulators. (Featured CME Topic).
Featured CME Topic: antibiotic resistance: Southern Medical Journal.
Southern Medical Journal featured CME topic: allergy.
Cardiopathia fantastica: the Cardiac variant of Munchausen syndrome.
Southern Medical Journal CME Topic: epidural intracranial abscess.
Southern Medical Journal CME Topic: hepatitis C infection.
Southern Medical Journal CME Topic: hypothyroidism.
Southern Medical Journal CME Topic: platypnea-orthodeoxia.
Southern Medical Journal featured CME topic: complementary and alternative medicine.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters